Purchases and Sales Made in Q1 2025 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q1 2025. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2025
Q1 2025
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-50.4K- 90.23% |
$1.85M - $2.74M
|
5.46K
$235K
|
|
|
May 14, 2025
Q1 2025
|
Candriam S.C.A.
|
SELL
|
- |
-53K- 23.28% |
$1.95M - $2.88M
|
175K
$7.5M
|
|
|
May 15, 2025
Q1 2025
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-55.9K- 12.46% |
$2.06M - $3.04M
|
393K
$16.9M
|
|
|
May 15, 2025
Q1 2025
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-56.5K- 5.53% |
$2.08M - $3.07M
|
966K
$41.5M
|
|
|
May 15, 2025
Q1 2025
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-128K- 61.84% |
$4.69M - $6.94M
|
78.8K
$3.39M
|
|
|
May 14, 2025
Q1 2025
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-182K- 87.19% |
$6.69M - $9.9M
|
26.8K
$1.15M
|
|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-370K- 11.06% |
$13.6M - $20.1M
|
2.97M
$128M
|
|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-382K- 22.81% |
$14M - $20.8M
|
1.29M
$55.6M
|
|
|
May 15, 2025
Q1 2025
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-604K- 48.53% |
$22.2M - $32.8M
|
641K
$27.6M
|
|
|
May 15, 2025
Q1 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-708K- 32.39% |
$26M - $38.5M
|
1.48M
$63.6M
|
|
|
May 15, 2025
Q1 2025
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-1.14M- 64.6% |
$42.1M - $62.2M
|
627K
$27M
|
|
|
May 15, 2025
Q1 2025
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-1.4M- 88.08% |
$51.3M - $75.9M
|
189K
$8.13M
|